CAR T cells generated by transposons could efficiently lyse target cells expressing CD19 antigen and secrete cytokines for immune activation, and engraftment of redirected T cells resulted in efficient CD19-specific tumor clearance in vivo in preclinical tumor xenograft models [50,78,125,127]. Here, CD19 is linked to neoplasm.